Proteome Sciences Signs Stroke Deal With Randox Laboratories
Proteome Sciences (PRM) today announced the first non-exclusive commercial license for its stroke biomarkers with Randox Laboratories - read the full news release. Under the terms of the license Randox will develop products for early diagnosis of stroke and subsequent monitoring of treatment outcomes. Financial terms provide Proteome Sciences with seven digit (US dollar) license and development [...]
Profits Warning from Software Radio Technology
On Friday, Software Radio Technology (SRT) released a trading update which in effect, was a profits warning in relation to market expectations. Full year sales are now expected to come in at around £6m (the expectation was for £10-15m) and profits at £100k. On the surface this is disappointing for shareholders and the shares closed down 6p [...]
Steady Progress at Anglo Pacific
Anglo Pacific today announced preliminary results for the year ended 31st December 2011 and these show that the company continue to make steady progress. The highlights are: – Record royalty income for the year of GBP 35.1 million, compared to GBP 30.1 million for the year ended December 31, 2010 – Record royalty cash flow per [...]
Software Radio Technology – Shareholder Webcast
Software Radio Technology have announced today that they will be holding a live shareholder webcast on 1st February at 9am. The webcast will be hosted by Simon Tucker, SRT’s CEO and questions can be submitted in advance through email and during the event via instant messaging. Registration is required to attend this webcast. We believe [...]
Proteome Sciences – Encouraging Year End Update
Proteome Sciences (PRM) today published an encouraging update on key activities: Stroke Biomarkers A Heads of Terms for a license of stroke biomarkers are to be signed shortly with the license due for completion during Q1 of 2012. Alzheimer’s Disease Study The 1,000 sample patient study in conjunction with King’s College London is in its [...]
UK Investment Market Overview for 2012
Everywhere you look at the moment the UK stock market is screaming doom and gloom. Double Dip Recession! Eurozone Crisis! Uncertainty in the Middle East! Unemployment Rising! Inflation Rising! In fact, it’s pretty hard to find any good news other than perhaps the FTSE100 has ONLY fallen by 5% this year - the FTSE250 declining by [...]